In vitro activity of LY264826, a new glycopeptide antibiotic, against gram-positive bacteria isolated from patients with cancer.

The in vitro activity of LY264826, a novel glycopeptide antibiotic produced by Amycolatopsis orientalis, was compared with those of vancomycin, teicoplanin, and oxacillin against 311 gram-positive clinical isolates from patients with cancer, LY264826 had lower MICs for 90% of isolates (MIC90) than v...

Cijeli opis

Bibliografski detalji

Izdano u:	Antimicrob Agents Chemother
Glavni autori:	Rolston, K V, Nguyen, H, Messer, M
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 1990
Teme:	Research Article
Online pristup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172013/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2149921/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.11.2137
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!